North Carolina Committee Passes Bill to Regulate Kratom and Hemp-Derived Consumables

A key North Carolina committee has approved legislation that will establish a regulatory and licensing system for both kratom and products made from hemp.

Hemp (left) and kratom (right).

The House Committee on Finance has given a favorable report to House Bill 563, allowing it to be referred to the Rules, Calendar, and Operations Committee (RCOC), the last step before it can be considered by the full House of Representatives. The RCOC held a public hearing on the measure this morning.

According to its official summary, the measure would:

  • Regulate the sale and distribution of hemp-derived consumable products and kratom products.
  • Require a license to sell, distribute, or manufacture hemp-derived consumable products and kratom products.
  • Ban hemp-derived consumable products from school grounds.

The bill states that “Kratom is a tropical tree native to Southeast Asia whose leaves contain two psychoactive ingredients, mitragynine and 7-hydroxymytragynine. The crushed leaves are generally smoked, brewed with tea, or placed into gel capsules.”

Consumption of kratom “produces both stimulant effects (in low doses) and sedative effects (in high doses)”, and it is “currently not a controlled substance and is unregulated and legal in North Carolina.”

House Bill 563 would change this, requiring a specific license in order to legally distribute kratom. A license would also be required to sell “hemp-derived consumable products”, defined as follows:

A hemp product intended for human ingestion or inhalation, that contains a concentration of not more than three-tenths of one percent (0.3%) on a dry weight basis total combined of delta-9 tetrahydrocannabinol, delta-7 tetrahydrocannabinol, delta-8 tetrahydrocannabinol, or delta-10 tetrahydrocannabinol, or any amount of another cannabinoid. This term does not include hemp products intended for topical application, or seeds or seed derived ingredients that are generally recognized as safe by the United States Food and Drug Administration (FDA).

This definition includes consumable products commonly referred to as “CBD”, “delta-7”, “delta-8”, and “delta-10”, and others. It “would not include topical products such as lotions or creams intended to be used externally, or items such as hemp milk that are derived from seed.”

The bill would provide sales restrictions on hemp-derived consumable products and prohibit the
following:

  • Selling a hemp-derived consumable product to a person under 18.
  • Distributing samples of a hemp-derived consumable product in or on a public street, sidewalk, or
    park.
  • Engaging in the business of selling hemp-derived consumable products without a valid license.
  • Selling a hemp-derived consumable product that has a concentration of more than 0.3% on a dry
    weight basis total combined of delta-9 tetrahydrocannabinol, delta-7 tetrahydrocannabinol, delta8 tetrahydrocannabinol, or delta-10 tetrahydrocannabinol.

In general, there would be no criminal penalties for violation, but civil penalties could be imposed by the
Department of Revenue (Department) as follows:

  • 1st violation – up to $500.
  • 2nd violation within 3 years – up to $750.
  • 3rd violation within 3 years of the 1st violation – up to $1,000 and 30 day suspension of license.
  • 4th or subsequent violation within 3 years of the 1st violation – up to $2,000 and either (i) license
    suspension for up to 1 year or (ii) license revocation.

In any case where the Department is authorized to suspend or revoke a license, the Department may accept an offer in compromise of up to $3,000. If the Department accepts the offer in compromise, it may suspend the license, but not revoke it. Additionally, in any case in which the Department imposes a penalty for a violation of selling a product with more than 0.3% THC the seller shall also pay to the Department the actual costs paid by the Alcohol Law Enforcement (ALE) Division for testing the product samples resulting in the violation.

House Bill 563 was filed by State Representative Jeffrey McNeeley along with a bipartisan coalition of 10 other lawmakers. You can find the full text of the measure by clicking here.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here.

More articles from The Marijuana Herald:

Rhode Island Lawmakers File Bill to Create “RICare” Universal Healthcare System, Ban Premiums and Copays

Rhode Island Lawmakers File Bill to Create “RICare” Universal Healthcare System, Ban Premiums and Copays

CBD May Help Limit the “Second Wave” of Brain Damage After Traumatic Brain Injury, Study Finds

CBD May Help Limit the “Second Wave” of Brain Damage After Traumatic Brain Injury, Study Finds

CB1 Activation Helps Speed Wound Healing, Reports Study

CB1 Activation Helps Speed Wound Healing, Reports Study

Florida Senate Committee to Vote Feb. 18 on Bill Tightening Low-THC Marijuana Rules and Expanding Buffer Zones for Dispensaries

Florida Senate Committee to Vote Feb. 18 on Bill Tightening Low-THC Marijuana Rules and Expanding Buffer Zones for Dispensaries

Study: CBD Kills Rare Ovarian Tumor Cells by Targeting TRPV2 Channel and Mitochondrial Pathway

Study: CBD Kills Rare Ovarian Tumor Cells by Targeting TRPV2 Channel and Mitochondrial Pathway

Edible Hemp Film Helped Keep Freeze-Dried Berries Fresher in Storage, Study Finds

Edible Hemp Film Helped Keep Freeze-Dried Berries Fresher in Storage, Study Finds

Maryland Cannabis Industry Generates $98.9 Million in Sales in January, Prices down 12% from January 2025

Maryland Cannabis Industry Generates $98.9 Million in Sales in January, Prices down 12% from January 2025

Utah Committee Advances Bill to Allow Medical Marijuana Telehealth Recommendations, Expand Low-THC Products in Pharmacies

Utah Committee Advances Bill to Allow Medical Marijuana Telehealth Recommendations, Expand Low-THC Products in Pharmacies

New York Bill Would Let Liquor Stores Sell Low-THC Cannabis Beverages, Taxed at 9% Wholesale and 13% Retail

New York Bill Would Let Liquor Stores Sell Low-THC Cannabis Beverages, Taxed at 9% Wholesale and 13% Retail

U.S. Congress: Legislation to End Cannabis Prohibition Nationwide and Allow Expungements Gains Sponsors from Nearly 30 States and D.C.

U.S. Congress: Legislation to End Cannabis Prohibition Nationwide and Allow Expungements Gains Sponsors from Nearly 30 States and D.C.

Bipartisan Oregon Bill Would Allow Physician-Supervised Ibogaine Treatment

Bipartisan Oregon Bill Would Allow Physician-Supervised Ibogaine Treatment

Virginia Bill to Require Hospitals to Allow Medical Marijuana for Terminally Ill Patients Approved by Committee

Virginia Bill to Require Hospitals to Allow Medical Marijuana for Terminally Ill Patients Approved by Committee

Tilray Expands UK Medical Supply Network Through New Distribution Deal With Smartway Pharmaceuticals

Tilray Expands UK Medical Supply Network Through New Distribution Deal With Smartway Pharmaceuticals

Virginia House Appropriations Committee Advances Bill to Legalize Recreational Cannabis Sales 16 to 6

Virginia House Appropriations Committee Advances Bill to Legalize Recreational Cannabis Sales 16 to 6

New York Legislature Passes Bill Allowing Marijuana Dispensaries Near Houses of Worship, Sends Measure to Governor

New York Legislature Passes Bill Allowing Marijuana Dispensaries Near Houses of Worship, Sends Measure to Governor

Florida Appeals Court Upholds State’s THC Limits on Hemp Products

Florida Appeals Court Upholds State’s THC Limits on Hemp Products

U.S. Congress: Legislation to Prevent Cannabis Businesses From Taking Tax Deductions Following Rescheduling Gains 15th Sponsor

U.S. Congress: Legislation to Prevent Cannabis Businesses From Taking Tax Deductions Following Rescheduling Gains 15th Sponsor

New York Senate Committee Advances Bill Allowing Parolees and Probationers to Work in Legal Marijuana Industry

New York Senate Committee Advances Bill Allowing Parolees and Probationers to Work in Legal Marijuana Industry